Does neoadjuvant therapy increase the incidence of anastomotic leakage after anterior resection for mid and low rectal cancer? A systematic review and meta-analysis

Colorectal Disease

Volumn 19, Issue 1, 2017, Pages 16-26

  Hu, M H ^a   Huang, R K ^a   Zhao, R S ^a   Yang, K L ^a   Wang, H ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

anastomotic leakage; neoadjuvant chemoradiotherapy; neoadjuvant radiotherapy; Rectal cancer

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ANASTOMOSIS LEAKAGE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CLINICAL EFFECTIVENESS; HUMAN; INCIDENCE; LONG TERM CARE; META ANALYSIS; OUTCOME ASSESSMENT; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RECTUM ANTERIOR RESECTION; RECTUM CANCER; REVIEW; SHORT COURSE THERAPY; SYSTEMATIC REVIEW; ADULT; ADVERSE EFFECTS; AGED; ANASTOMOSIS; ANASTOMOTIC LEAK; CHEMORADIOTHERAPY; FEMALE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RECTAL NEOPLASMS; RISK FACTOR; TIME FACTOR;

ADULT; AGED; ANASTOMOSIS, SURGICAL; ANASTOMOTIC LEAK; CHEMORADIOTHERAPY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RECTAL NEOPLASMS; RISK FACTORS; TIME FACTORS;

EID: 85008367698     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.13424     Document Type: Review

References (51)

1. Martin ST, Heneghan HM, Winter DC. Systematic review of outcomes after intersphincteric resection for low rectal cancer. Br J Surg 2012; 99: 603–12.
2. Branagan G, Finnis D. Prognosis after anastomotic leakage in colorectal surgery. Dis Colon Rectum 2005; 48: 1021–6.
3. den Dulk M, Smit M, Peeters KC et al. A multivariate analysis of limiting factors for stoma reversal in patients with rectal cancer entered into the total mesorectal excision (TME) trial: a retrospective study. Lancet Oncol 2007; 8: 297–303.
4. Matthiessen P, Hallbook O, Rutegard J, Sjodahl R. Population-based study of risk factors for postoperative death after anterior resection of the rectum. Br J Surg 2006; 93: 498–503.
5. Merkel S, Wang WY, Schmidt O et al. Locoregional recurrence in patients with anastomotic leakage after anterior resection for rectal carcinoma. Colorectal Dis 2001; 3: 154–60.
6. Mongin C, Maggiori L, Agostini J, Ferron M, Panis Y. Does anastomotic leakage impair functional results and quality of life after laparoscopic sphincter-saving total mesorectal excision for rectal cancer? A case-matched study. Int J Colorectal Dis 2014; 29: 459–67.
7. Ptok H, Marusch F, Meyer F, Schubert D, Gastinger I, Lippert H. Impact of anastomotic leakage on oncological outcome after rectal cancer resection. Br J Surg 2007; 94: 1548–54.
8. Walker KG, Bell SW, Rickard MJ et al. Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg 2004; 240: 255–9.
9. Koh PK, Tang CL, Eu KW, Samuel M, Chan E. A systematic review of the function and complications of colonic pouches. Int J Colorectal Dis 2007; 22: 543–8.
10. Shivnani AT, Small WJ, Stryker SJ et al. Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg 2007; 193(389–93): 393–4.
11. Wang T, Wang J, Deng Y, Wu X, Wang L. Neoadjuvant therapy followed by local excision and two-stage total mesorectal excision: a new strategy for sphincter preservation in locally advanced ultra-low rectal cancer. Gastroenterol Rep (Oxf) 2014; 2: 37–43.
12. Geisler D, Marks J, Marks G. Laparoscopic colorectal surgery in the irradiated pelvis. Am J Surg 2004; 188: 267–70.
13. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1–34.
14. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603–5.
15. Nisar PJ, Lavery IC, Kiran RP. Influence of neoadjuvant radiotherapy on anastomotic leak after restorative resection for rectal cancer. J Gastrointest Surg 2012; 16: 1750–7.
16. Denost Q, Laurent C, Paumet T, Quintane L, Martenot M, Rullier E. Laparoscopic surgery for rectal cancer: preoperative radiochemotherapy versus surgery alone. Surg Endosc 2012; 26: 1878–83.
17. Garlipp B, Ptok H, Schmidt U, Meyer F, Gastinger I, Lippert H. Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection. Results of the Quality Assurance in Rectal Cancer Surgery multicenter observational trial. Langenbecks Arch Surg 2010; 395: 1031–8.
18. Akiyoshi T, Kuroyanagi H, Oya M et al. Safety of laparoscopic total mesorectal excision for low rectal cancer with preoperative chemoradiation therapy. J Gastrointest Surg 2009; 13: 521–5.
19. Martel G, Al-Suhaibani Y, Moloo H et al. Neoadjuvant therapy and anastomotic leak after tumor-specific mesorectal excision for rectal cancer. Dis Colon Rectum 2008; 51: 1195–201.
20. Rosati R, Bona S, Romario UF, Elmore U, Furlan N. Laparoscopic total mesorectal excision after neoadjuvant chemoradiotherapy. Surg Oncol 2007; 16(Suppl. 1): S83–9.
21. Navarro GV, Mompean JA, Aguera QH et al. Influence of the neo-adjuvant radiochemotherapy as a factor in the surgical treatment of rectal cancer by expert surgeon. A comparative study. Int J Colorectal Dis 2007; 22: 1233–8.
22. Doeksen A, Tanis PJ, Vrouenraets BC, Gooszen JA, van Lanschot JJ, van Tets WF. Outcome of rectal cancer surgery after the introduction of preoperative radiotherapy in a low-volume hospital. J Gastrointest Cancer 2007; 38: 63–70.
23. Buie WD, MacLean AR, Attard JA, Brasher PM, Chan AK. Neoadjuvant chemoradiation increases the risk of pelvic sepsis after radical excision of rectal cancer. Dis Colon Rectum 2005; 48: 1868–74.
24. Korkolis DP, Plataniotis GD, Gondikakis E et al. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer. Int J Colorectal Dis 2006; 21: 1–6.
25. Valero G, Lujan JA, Hernandez Q et al. Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications. Int J Colorectal Dis 2003; 18: 495–9.
26. Enker WE, Merchant N, Cohen AM et al. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg 1999; 230: 544–52, 552–4.
27. Wijesuriya SRE, Hewavisenthi J, Deen KI. Patients with rectal cancer having neoadjuvant chemoradiation do not have increased complications of ileostomy closure. Ceylon Med J 2010; 55: 115–7.
28. Hassan I, Larson DW, Wolff BG et al. Impact of pelvic radiotherapy on morbidity and durability of sphincter preservation after coloanal anastomosis for rectal cancers. Dis Colon Rectum 2008; 51: 32–7.
29. Kao PM, Chang SMP, Wang LM et al. The impact of preoperative chemoradiotherapy on advanced low rectal cancer. J Surg Oncol 2010; 102: 771–7.
30. Salmenkyla S, Kouri M, Osterlund P et al. Does preoperative radiotherapy with postoperative chemotherapy increase acute side-effects and postoperative complications of total mesorectal excision? Report of the randomized Finnish rectal cancer trial. Scand J Surg 2012; 101: 275–82.
31. Sauer R, Fietkau R, Wittekind C et al. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis 2003; 5: 406–15.
32. Park JH, Yoon SM, Yu CS, Kim JH, Kim TW, Kim JC. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer. Cancer 2011; 117: 3703–12.
33. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 1995; 75: 2269–75.
34. Gates GD. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet 1996; 348: 1605–10.
35. Sebag-Montefiore D, Stephens RJ, Steele R et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373: 811–20.
36. Påhlman L. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Br J Surg 1993; 80: 1333–6.
37. Marijnen CA, Kapiteijn E, van de Velde CJ et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002; 20: 817–25.
38. Huser N, Michalski CW, Erkan M et al. Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann Surg 2008; 248: 52–60.
39. Matthiessen P, Hallbook O, Rutegard J, Simert G, Sjodahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg 2007; 246: 207–14.
40. Iyer S, Balasubramanian D. Management of radiation wounds. Indian J Plast Surg 2012; 45: 325–31.
41. Maggiori L, Bretagnol F, Aslam MI et al. Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision? Surgery 2014; 155: 468–75.
42. van Gijn W, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011; 12: 575–82.
43. De Caluwe L, Van Nieuwenhove Y, Ceelen WP. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev 2013; 2: D6041.
44. Gosens MJ, Klaassen RA, Tan-Go I et al. Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res 2007; 13: 6617–23.
45. Habr-Gama A, Perez RO, Proscurshim I et al. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 2008; 71: 1181–8.
46. Moore HG, Gittleman AE, Minsky BD et al. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 2004; 47: 279–86.
47. de Campos-Lobato LF, Geisler DP, Da LMA, Stocchi L, Dietz D, Kalady MF. Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery. J Gastrointest Surg 2011; 15: 444–50.
48. Wasserberg N. Interval to surgery after neoadjuvant treatment for colorectal cancer. World J Gastroenterol 2014; 20: 4256–62.
49. Wong RK, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007: D2102.
50. Baeten CI, Castermans K, Lammering G et al. Effects of radiotherapy and chemotherapy on angiogenesis and leukocyte infiltration in rectal cancer. Int J Radiat Oncol Biol Phys 2006; 66: 1219–27.
51. Evans J, Patel U, Brown G. Rectal cancer: primary staging and assessment after chemoradiotherapy. Semin Radiat Oncol 2011; 21: 169–77.